Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Thymoma 1Thymic epithelial tumor 1Ovarian Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 4seribantumab 1pembrolizumab 1gedatolisib 1fluciclovine F-18 1TP protocol 1Standard of Care 1Oxaliplatin 1Music Therapy 1Leucovorin 1Letrozole 1Immunoglobulin G 1Imatinib Mesylate 1Imagery, Psychotherapy 1Hysterectomy 1Fluorouracil 1Device Removal 1Cisplatin 1Celecoxib 1Carboplatin 1Bupivacaine 1Bevacizumab 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uterine Neoplasms × TP protocol × Clear all
NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

University of Oklahoma

Phase 2 Terminated
21 enrolled 7 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡